{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:25:06Z","timestamp":1793496306650,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01005-y","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:29:17Z","timestamp":1761665357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of potential natural BCL-2 inhibitors for leukemia through an integrated virtual screening approach"],"prefix":"10.1186","volume":"26","author":[{"given":"Uddalak","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Mukunthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"crossref","unstructured":"Huang J, Chan SC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE et al. Disease burden, risk factors, and trends of leukaemia: A global analysis. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.904292"},{"key":"1005_CR2","doi-asserted-by":"crossref","unstructured":"Alam M, Ali S, Mohammad T, Hasan GM, Yadav DK, Hassan MI. B cell lymphoma 2: A potential therapeutic target for cancer therapy. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms221910442"},{"key":"1005_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.molimm.2014.07.018","volume":"63","author":"J Arockiaraj","year":"2015","unstructured":"Arockiaraj J, Palanisamy R, Arasu A, Sathyamoorthi A, Kumaresan V, Bhatt P, et al. An anti-apoptotic B-cell lymphoma-2 (BCL-2) from Channa striatus: sequence analysis and delayed and advanced gene expression in response to fungal, bacterial and Poly I:C induction. Mol Immunol. 2015;63:586\u201394.","journal-title":"Mol Immunol"},{"key":"1005_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.dci.2013.08.004","volume":"41","author":"D Gao","year":"2013","unstructured":"Gao D, Xu Z, Zhang X, Zhu C, Wang Y, Min W. Cadmium triggers kidney cell apoptosis of purse red common carp (Cyprinus carpio) without caspase-8 activation. Dev Comp Immunol. 2013;41:728\u201337.","journal-title":"Dev Comp Immunol"},{"key":"1005_CR5","doi-asserted-by":"crossref","unstructured":"Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12.","DOI":"10.3389\/fonc.2022.985363"},{"key":"1005_CR6","first-page":"1","volume":"2016\u2013January","author":"D Taylor","year":"2015","unstructured":"Taylor D. The pharmaceutical industry and the future of drug development. Issues Environ Sci Technol. 2015;2016\u2013January:1\u201333.","journal-title":"Issues Environ Sci Technol"},{"key":"1005_CR7","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.7150\/thno.64233","volume":"12","author":"E Valentini","year":"2022","unstructured":"Valentini E, D\u2019Aguanno S, Di Martile M, Montesano C, Ferraresi V, Patsilinakos A, et al. Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules. Theranostics. 2022;12:2427\u201344.","journal-title":"Theranostics"},{"key":"1005_CR8","doi-asserted-by":"crossref","unstructured":"Zhou Jyi, Yang Rrui, Chang J, Song J, Fan Z sheng, Zhang Yhui et al. Discovery and identification of a novel small molecule BCL-2 inhibitor that binds to the BH4 domain. Acta Pharmacol Sin. 2022;44:475\u201385.","DOI":"10.1038\/s41401-022-00936-0"},{"key":"1005_CR9","doi-asserted-by":"crossref","unstructured":"Almansour NM, Allemailem KS, Abd El Aty AA, Ismail EIF, Ibrahim MAA. In Silico mining of natural products atlas (NPAtlas) database for identifying effective Bcl-2 inhibitors: molecular docking, molecular dynamics, and pharmacokinetics characteristics. Molecules. 2023;28.","DOI":"10.3390\/molecules28020783"},{"key":"1005_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12032-021-01513-x","volume":"38","author":"X Lv","year":"2021","unstructured":"Lv X, Jiang Y, Wang X, Xie HQ, Dou G, Wang J, et al. Computational study on novel natural inhibitors targeting BCL2. Med Oncol. 2021;38:94.","journal-title":"Med Oncol"},{"key":"1005_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-020-00478-9","volume":"13","author":"M Sorokina","year":"2021","unstructured":"Sorokina M, Merseburger P, Rajan K, Yirik MA, Steinbeck C. COCONUT online: collection of open natural products database. J Cheminform. 2021;13:1\u201313.","journal-title":"J Cheminform"},{"key":"1005_CR12","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, et al. OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput. 2021;17:4291\u2013300.","journal-title":"J Chem Theory Comput"},{"key":"1005_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-023-03955-5","volume":"21","author":"M Ganji","year":"2023","unstructured":"Ganji M, Bakhshi S, Shoari A, Ahangari Cohan R. Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular Docking studies against bladder cancer. J Transl Med. 2023;21:1\u201322.","journal-title":"J Transl Med"},{"key":"1005_CR14","doi-asserted-by":"crossref","unstructured":"Yu Y, Dong H, Peng Y, Welsh WJ. QSAR-Based computational approaches to accelerate the discovery of Sigma-2 receptor (S2R) ligands as therapeutic drugs. Molecules. 2021;26.","DOI":"10.3390\/molecules26175270"},{"key":"1005_CR15","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO. Virtual screening workflow development guided by the receiver operating characteristic curve approach. Application to high-throughput Docking on metabotropic glutamate receptor subtype 4. J Med Chem. 2005;48:2534\u201347.","journal-title":"J Med Chem"},{"key":"1005_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/ci600426e","volume":"47","author":"JF Truchon","year":"2007","unstructured":"Truchon JF, Bayly CI. Evaluating virtual screening methods: good and bad metrics for the early recognition problem. J Chem Inf Model. 2007;47:488\u2013508.","journal-title":"J Chem Inf Model"},{"key":"1005_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3:1\u201314.","journal-title":"J Cheminform"},{"key":"1005_CR18","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55:6582\u201394.","journal-title":"J Med Chem"},{"key":"1005_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski RA, Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov\u00e1 RS, Thornton JM. PDBsum: structural summaries of PDB entries. Protein Sci. 2018;27:129\u201334.","journal-title":"Protein Sci"},{"key":"1005_CR20","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1021\/acs.jcim.1c00301","volume":"61","author":"SJ Mahdizadeh","year":"2021","unstructured":"Mahdizadeh SJ, Thomas M, Eriksson LA. Reconstruction of the Fas-Based Death-Inducing signaling complex (DISC) using a Protein-Protein Docking Meta-Approach. J Chem Inf Model. 2021;61:3543\u201358.","journal-title":"J Chem Inf Model"},{"key":"1005_CR21","doi-asserted-by":"crossref","unstructured":"Jawarkar RD, Sharma P, Jain N, Gandhi A, Mukerjee N, Al-Mutairi AA et al. QSAR, Molecular docking, MD simulation and MMGBSA calculations approaches to recognize concealed pharmacophoric features requisite for the optimization of ALK tyrosine kinase inhibitors as anticancer leads. Molecules. 2022;27.","DOI":"10.3390\/molecules27154951"},{"key":"1005_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/07391102.2023.2192798","volume":"42","author":"MR Islam","year":"2024","unstructured":"Islam MR, Osman OI, Hassan WMI. Identifying novel therapeutic inhibitors to target FMS-like tyrosine kinase-3 (FLT3) against acute myeloid leukemia: a molecular docking, molecular dynamics, and DFT study. J Biomol Struct Dyn. 2024;42:82\u2013100.","journal-title":"J Biomol Struct Dyn"},{"key":"1005_CR23","first-page":"1","volume":"2017 71","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;2017 71:7:1\u201313.","journal-title":"Sci Rep"},{"key":"1005_CR24","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024;52:W513\u201320.","journal-title":"Nucleic Acids Res"},{"key":"1005_CR25","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024;52:W422\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1005_CR26","doi-asserted-by":"publisher","first-page":"8919","DOI":"10.1021\/acs.jctc.3c00777","volume":"19","author":"H Kim","year":"2023","unstructured":"Kim H, F\u00e1bi\u00e1n B, Hummer G. Neighbor list artifacts in molecular dynamics simulations. J Chem Theory Comput. 2023;19:8919\u201329.","journal-title":"J Chem Theory Comput"},{"key":"1005_CR27","doi-asserted-by":"crossref","unstructured":"Elhady SS, Abdelhameed RFA, Malatani RT, Alahdal AM, Bogari HA, Almalki AJ et al. Molecular docking and dynamics simulation study of hyrtios erectus isolated scalarane sesterterpenes as potential SARS-CoV-2 dual target inhibitors. Biology (Basel). 2021;10.","DOI":"10.3390\/biology10050389"},{"key":"1005_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess B, Van Der Kutzner C, Lindahl E. GROMACS 4: algorithms for highly Efficient, Load-Balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4:435\u201347.","journal-title":"J Chem Theory Comput"},{"key":"1005_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2018.01.074","volume":"420","author":"MT Islam","year":"2018","unstructured":"Islam MT, Ali ES, Uddin SJ, Islam MA, Shaw S, Khan IN, et al. Andrographolide, a diterpene lactone from andrographis paniculata and its therapeutic promises in cancer. Cancer Lett. 2018;420:129\u201345.","journal-title":"Cancer Lett"},{"key":"1005_CR30","doi-asserted-by":"publisher","first-page":"22799","DOI":"10.3390\/molecules201219880","volume":"20","author":"T Kaserer","year":"2015","unstructured":"Kaserer T, Beck KR, Akram M, Odermatt A, Schuster D, Willett P. Pharmacophore models and Pharmacophore-Based virtual screening: concepts and applications exemplified on hydroxysteroid dehydrogenases. Molecules. 2015;20:22799.","journal-title":"Molecules"},{"key":"1005_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13880209.2023.2168703","volume":"61","author":"Y Yang","year":"2023","unstructured":"Yang Y, Yang Y, Shen Y, Liu J, Zeng Y, Wei C, et al. Exploring the Pharmacological mechanisms of Shuanghuanglian against T-cell acute lymphoblastic leukaemia through network Pharmacology combined with molecular Docking and experimental validation. Pharm Biol. 2023;61:259\u201370.","journal-title":"Pharm Biol"},{"key":"1005_CR32","doi-asserted-by":"publisher","first-page":"8898","DOI":"10.3390\/ijms23168898","volume":"23","author":"HR Teles","year":"2022","unstructured":"Teles HR, Ferreira LLG, Valli M, Coelho F, Andricopulo AD. Hierarchical clustering and Target-Independent QSAR for antileishmanial Oxazole and oxadiazole derivatives. Int J Mol Sci. 2022;23:8898.","journal-title":"Int J Mol Sci"},{"key":"1005_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/10799893.2020.1731533","volume":"40","author":"SH Satuluri","year":"2020","unstructured":"Satuluri SH, Katari SK, Pasala C, Amineni U. Novel and potent inhibitors for dihydropteroate synthase of Helicobacter pylori. J Recept Signal Transduct Res. 2020;40:246\u201356.","journal-title":"J Recept Signal Transduct Res"},{"key":"1005_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10822-023-00499-0","volume":"37","author":"M Taylor","year":"2023","unstructured":"Taylor M, Ho J. MM\/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4Zn. J Comput Aided Mol Des. 2023;37:167\u201382.","journal-title":"J Comput Aided Mol Des"},{"key":"1005_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1517\/14728214.2010.515210","volume":"16","author":"AS Azmi","year":"2010","unstructured":"Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Emerging Bcl-2 inhibitors for the treatment of cancer. Expert Opin Emerg Drugs. 2010;16:59.","journal-title":"Expert Opin Emerg Drugs"},{"key":"1005_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14020113","volume":"14","author":"MI Nagy","year":"2021","unstructured":"Nagy MI, Darwish KM, Kishk SM, Tantawy MA, Nasr AM, Qushawy M, et al. Design, Synthesis, anticancer Activity, and solid lipid nanoparticle formulation of Indole- and Benzimidazole-Based compounds as Pro-Apoptotic agents targeting Bcl-2 protein. Pharmaceuticals (Basel). 2021;14:1\u201337.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1005_CR37","first-page":"1","volume":"14","author":"H Wei","year":"2023","unstructured":"Wei H, Wang H, Wang G, Qu L, Jiang L, Dai S, et al. Structures of p53\/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity. Nat Commun 2023 141. 2023;14:1\u201313.","journal-title":"Nat Commun 2023 141"},{"key":"1005_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1083\/jcb.201102027","volume":"194","author":"H Dai","year":"2011","unstructured":"Dai H, Smith A, Meng XW, Schneider PA, Pang YP, Kaufmann SH. Transient binding of an activator BH3 domain to the bak BH3-binding groove initiates bak oligomerization. J Cell Biol. 2011;194:39.","journal-title":"J Cell Biol"},{"key":"1005_CR39","first-page":"791","volume":"46","author":"AK Oyebamiji","year":"2023","unstructured":"Oyebamiji AK, Akintelu SA, Odelade KA, Adetuyi B, Akintayo ET, Akintayo CO, ELECTRON WITHDRAWING GROUP EFFECT ON BIOLOGICAL ACTIVITIES OF PYRIMIDINE HYBRIDS AS POTENTIAL ANTI-MATRIX METALLOPROTEINASE-7, et al. Quim Nova. 2023;46:791\u20137.","journal-title":"Quim Nova"},{"key":"1005_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","volume":"59","author":"M Elmeliegy","year":"2020","unstructured":"Elmeliegy M, Vourvahis M, Guo C, Wang DD. Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical Drug-Drug interaction studies. Clin Pharmacokinet. 2020;59:699\u2013714.","journal-title":"Clin Pharmacokinet"},{"key":"1005_CR41","doi-asserted-by":"crossref","unstructured":"Lee J, Beers JL, Geffert RM, Jackson KD. A review of CYP-Mediated drug interactions: mechanisms and in vitro drug-drug interaction assessment. Biomolecules. 2024;14.","DOI":"10.3390\/biom14010099"},{"key":"1005_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40263-024-01138-4","volume":"39","author":"CU Correll","year":"2025","unstructured":"Correll CU, Kim E, Sliwa JK, Hamm W, Gopal S, Mathews M, et al. Correction: Pharmacokinetic characteristics of Long-Acting injectable antipsychotics for schizophrenia: an overview. CNS Drugs. 2025;39:111\u20132.","journal-title":"CNS Drugs"},{"key":"1005_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-021-00543-5","volume":"23","author":"Y Fan","year":"2022","unstructured":"Fan Y, Fu Y, Zhou Y, Liu Y, Hao B, Shang R. Acute, subacute oral toxicity and Ames test of Py-mulin: an antibacterial drug candidate. BMC Pharmacol Toxicol. 2022;23:1\u201312.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1005_CR44","first-page":"1","volume":"7","author":"F Orme\u00f1o","year":"2024","unstructured":"Orme\u00f1o F, General IJ. Convergence and equilibrium in molecular dynamics simulations. Commun Chem 2024 71. 2024;7:1\u201311.","journal-title":"Commun Chem 2024 71"},{"key":"1005_CR45","first-page":"1","volume":"11","author":"PCT Souza","year":"2020","unstructured":"Souza PCT, Thallmair S, Conflitti P, Ram\u00edrez-Palacios C, Alessandri R, Raniolo S, et al. Protein\u2013ligand binding with the coarse-grained martini model. Nat Commun 2020 111. 2020;11:1\u201311.","journal-title":"Nat Commun 2020 111"},{"key":"1005_CR46","doi-asserted-by":"publisher","first-page":"3502514","DOI":"10.1155\/2018\/3502514","volume":"2018","author":"Y Fu","year":"2018","unstructured":"Fu Y, Zhao J, Chen Z. Insights into the molecular mechanisms of protein-Ligand interactions by molecular Docking and molecular dynamics simulation: A case of oligopeptide binding protein. Comput Math Methods Med. 2018;2018:3502514.","journal-title":"Comput Math Methods Med"},{"key":"1005_CR47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.foodhyd.2016.05.040","volume":"61","author":"K Wang","year":"2016","unstructured":"Wang K, Arntfield SD. Modification of interactions between selected volatile flavour compounds and salt-extracted pea protein isolates using chemical and enzymatic approaches. Food Hydrocoll. 2016;61:567\u201377.","journal-title":"Food Hydrocoll"},{"key":"1005_CR48","doi-asserted-by":"crossref","unstructured":"Chikalov I, Yao P, Moshkov M, Latombe JC. Learning probabilistic models of hydrogen bond stability from molecular dynamics simulation trajectories. BMC Bioinformatics. 2011;12 SUPPL 1:1\u20136.","DOI":"10.1186\/1471-2105-12-S1-S34"},{"key":"1005_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","volume":"1084","author":"CC David","year":"2014","unstructured":"David CC, Jacobs DJ. Principal component analysis: A method for determining the essential dynamics of proteins. Methods Mol Biol. 2014;1084:193.","journal-title":"Methods Mol Biol"},{"key":"1005_CR50","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1016\/j.csbj.2023.07.017","volume":"21","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteins. Comput Struct Biotechnol J. 2023;21:3760\u20137.","journal-title":"Comput Struct Biotechnol J"},{"key":"1005_CR51","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1021\/jo0201225","volume":"67","author":"J Ribas","year":"2002","unstructured":"Ribas J, Cubero E, Luque FJ, Orozco M. Theoretical study of alkyl-\u03c0 and aryl-\u03c0 interactions. Reconciling theory and experiment. J Org Chem. 2002;67:7057\u201365.","journal-title":"J Org Chem"},{"key":"1005_CR52","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1021\/acs.jctc.5b00003","volume":"11","author":"MGS Costa","year":"2015","unstructured":"Costa MGS, Batista PR, Bisch PM, Perahia D. Exploring free energy landscapes of large conformational changes: molecular dynamics with excited normal modes. J Chem Theory Comput. 2015;11:2755\u201367.","journal-title":"J Chem Theory Comput"},{"key":"1005_CR53","first-page":"1","volume":"11","author":"LP Yang","year":"2020","unstructured":"Yang LP, Zhang L, Quan M, Ward JS, Ma YL, Zhou H, et al. A supramolecular system that strictly follows the binding mechanism of conformational selection. Nat Commun 2020 111. 2020;11:1\u20139.","journal-title":"Nat Commun 2020 111"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01005-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:03:54Z","timestamp":1761703434000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-01005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01005-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}